BOT is about to release results (soon) on their psoriasis drug.
They're testing this on a larger cohort of patients, hence the phase 1b trial.
However, it's important to note that theyve already seen positive results for this drug in a patient. Not an animal, not a stem cell derived model. A human.
Expanding this to a larger cohort should see similar (positive) results due to the genetics of the condition. Genetic variability is lesser, and derma conditions of the more superficial layers are easier to treat without being prone to changes due to pigmentation deposits and other genetic factors albeit environmental factors.
Like any bio company, there is a chance this won't be as good as I think. However, assuming they're controlling their patient samples (they would be) I'd take a stab to guess that we may be in for a nice month.
Also someone linked the trial outline a while back (can't find it but it's on the national registry). It's in all states and includes large patient groups with a very comprehensive outline. You don't spend that sort of money taking a drug to trial if you didn't think it'll have good results; you rule that out in-vitro models. That's the point.
Lest we forget we have 3 products. A new director. A some rapport overseas and from dermatologists already - that's nice.
Results are around the corner.
GLTAH. DYOR.
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-399
-
- There are more pages in this discussion • 13,886 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
-0.015(4.17%) |
Mkt cap ! $624.4M |
Open | High | Low | Value | Volume |
36.0¢ | 36.5¢ | 34.0¢ | $1.179M | 3.382M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 101976 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 151653 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 101976 | 0.345 |
17 | 639633 | 0.340 |
4 | 137621 | 0.335 |
9 | 355203 | 0.330 |
3 | 333710 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 151653 | 1 |
0.355 | 396605 | 4 |
0.360 | 340133 | 4 |
0.365 | 212000 | 4 |
0.370 | 656332 | 10 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online